| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |